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http://dx.doi.org/10.1016/j.jfma.201This study aimed to evaluate the feasibility of the chemical method to analyze exhaled breath
condensate (EBC) leukotriene B4 (LTB4) level in humans. High-performance liquid chromatog-
raphy with a UV detector was applied to quantify the inflammatory biomarker. The LTB4 con-
centration in the concentrated pooled EBC samples was 1.19 ng/mL, and the average LTB4
concentration of each EBC sample was 15.38 ng/mL. This analytical technique was feasible
to evaluate the levels of inflammatory mediators such as LTB4 in human EBCs without any
complicated sample pretreatment processes.
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Measuring EBC LTB4 in adults by HPLC/UV 567Introduction
Leukotriene B4 (LTB4) is a potent chemokine and becomes
the neutrophil chemotaxis once activated.1,2 Increased
LTB4 and leukotriene E4 (LTE4) levels in specimens such as
sputum, bronchoalveolar lavages, nasal capacity secre-
tions, and exhaled breath condensates (EBCs) can reflect
the severity of human airway inflammation.2 Developing a
reproducible, highly sensitive, and specific analytical
method to measure EBC biomarkers even at low concen-
trations is important.1,3,4 LTB4 and LTE4 in EBCs were
measured by gas chromatography (GC)5 and liquid chro-
matography (LC),6e8 in addition to enzyme-linked immu-
noassays and fluorometric assays. The GC method needed
derivatization prior to analysis.7 Immunoassay methods
often lacked specificity.7 Ca´p et al5 measured the EBC LTB4
and LTE4 levels in children and adults with asthma and in
healthy adults and children by GC/mass spectrometry (MS),
and proved that EBC LTB4 concentrations of the group with
asthma were statistically higher than those of the healthy
group. High-performance liquid chromatography (HPLC)
was able to separate LTB4, LTB5, and 6-trans-LTB4 of EBCs,
being pooled from 22 patients with different lung diseases.8
Pelclova´ et al9 used LC/electrospray ionizationeMS to
quantify EBC leukotrienes in silicosis patients and healthy
adults, and demonstrated that LTB4 concentrations be-
tween the patients (26.8  3.3 pg/mL) and healthy adults
(29.4  7.8 pg/mL) did not show any significant difference.
Until recently, no standardized chemical analytical
methods have been established for the measurement of EBC
biomarkers.4,9e11 This study aimed to quantify EBC LTB4 in
healthy adults using a HPLC with UV detector (HPLC/UV).Materials and methods
EBC collection
The study protocol was approved by the institutional review
board of Chang Gung Memorial Hospital, Taipei, Taiwan.
Prior to participating in the study, informed written consent
was obtained from each individual. Sixty undergraduates
with no history of allergies or pulmonary disease and no
smoking behavior were recruited from Chang Gung Uni-
versity. Age range of recruited adults was 20e23 years
(average 20.5 years). The percentages of female and male
adults were 73.3% and 26.7%, respectively. The participants
had no symptoms of airway infection and used drugs prior
to EBC collection. Resulting EBCs (volumes ranging from
1 mL to 3 mL) were collected in a condensing chamber
(Ecoscreen; Jaeger Toennies, Hoechberg, Germany) and
stored at 80C.12,13
Standard preparation
The LTB4 stock solution (10 ng/mL) was diluted from a
100 ng/mL LTB4 solution (Cayman Chemical Co., Ann Arbor,
MI, USA) with ethanol (purity 95%; Taiwan Sugar Co.,
Tainan City, Taiwan). Concentrations of calibration stan-
dards ranged from 1.0 to 10.0 ng/ml for LTB4 were diluted
from the stock solutions.Sample pretreatment
Prior to HPLC analysis, all EBC samples were treated with
argon at a flow rate of 3.5 L/min for 10 minutes to elimi-
nate CO2 and their water content was removed using a
freeze dryer (Labconco Freeze Dryer 7750000; Labconco
Corp, Kansas City, MO, USA). Ethanol (50 mL) was added to
the dry EBC samples. To increase the amount of leukotri-
enes, 5 mL of each EBCeethanol solution was taken and
pooled to form a 300-mL sample. Ethanol was then removed
under a nitrogen stream. Finally, ethanol was added up to a
volume of 10 mL for HPLC quantitative analysis.
Analytical conditions
Liquid chromatographic separation was performed on an Agi-
lent series 1200 HPLC system (Santa Clara, CA, USA). Chro-
matography was performed on an Agilent Eclipse XDB-C18
column (2.1  150 mm2, 5 mm) using methanol (purity >95%,
Mallinckordt Baker, Center Valley, PA, USA) and an aqueous
solution of 10 mM ammonium acetate (purity >99%; Fluka
Analytical, Buchs, Switzerland) (70:30, v/v) as the mobile
phase and at a flow rate of 0.1 mL/min in an isocratic condi-
tion. The detection was accomplished with a UVevisible de-
tector (HP-G1365D; Santa Clara, CA, USA). The wavelengths
were set at 270 nmfor LTB4 and 280 nm for LTE4. The retention
times of LTB4 and LTE4 were 9.3 and 12.1 minutes, respec-
tively. The injection volume was 2 mL.
Results
The peak areas for LTB4 were plotted versus LTB4 concen-
trations; good linearity was observed over the examination
concentrations ranging from 1.0 ng/mL to10 ng/mL with an r-
square (r2) value of 0.9994. Using the calibration curve, the
LTB4 concentration of thepooledEBC samplewas calculated.
The chromatogram of the pooled EBC sample is shown in
Fig. 1. The retention timewas 9.2minutes for LTB4. The LTB4
concentrations in EBC samples were calculated as follows:
The LTB4 concentration in the sample (injected into the
HPLC column), after being deducted from the calibra-
tion curve, was 1190 pg/mL.
1190 pg/mL  10 mL (final concentrated pooled sample
volume)Z 11,900 pg (LTB4 mass in concentrated pooled
EBC samples)
11,900 pg  (50/5) (concentration factor) O 128.94 mL
(total originalEBCvolume)O60 (sample size)Z15.38pg/
mL (average mass per EBC sample)
The concentration of LTB4 in the concentrated pooled
sample was 1.19 ng/mL. The average EBC LTB4 level of the
adult participants was 15.38 pg/mL.
Discussion
This simple HPLC/UV method was able to detect the LTB4
level in humans after concentrating EBC samples by
Figure 1 Chromatogram of the pooled exhaled breath condensate samples.
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terferences. No complicated chemical pretreatment5 or
filtration8 was needed. A GC/MS study indicated that the
EBC LTB4 (205 pg/mL) and LTE4 (135 pg/mL) levels in
asthmatic patients were significantly higher than those in
healthy adults (LTB4 79 pg/mL and LTE4 74 pg/mL).
5
Steroid-naive atopic children had a higher EBC LTB4 level
(255.1 pg) than healthy controls (87.5 pg), as found by LC/
MS.6 Those studies reported that the EBC LTB4 and LTE4
levels of asthmatic patients increased three-fold compared
with the healthy group and would be detectable by the
present method. The detection limits of this simple HPLC/
UV method were higher than the MS methods5,6 as the UV
detection limit is generally 10-fold higher than the MS
detection limit.14 This explains why LTB4 in a single EBC
sample could not be detected in this study. The small
allowable injection volume of this particular HPLC column
was another limitation. Further studies should be con-
ducted considering an alternative column allowing a large
injection volume to increase the LTE masses on the column.
Additionally, this study primarily evaluated the feasibility
of HPLC/UV to analyze EBC LTB4 levels in healthy adults.
Further studies are needed to evaluate the concentration
distribution of EBC LTB4 levels in patients with allergic
respiratory diseases using the HPLC/UV method.References
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